LUNG DISEASES
Clinical trials for LUNG DISEASES explained in plain language.
Never miss a new study
Get alerted when new LUNG DISEASES trials appear
Sign up with your email to follow new studies for LUNG DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood clot catheter study pulled before it started
Disease control TerminatedThis study planned to test a special tube called the Versus Catheter for dissolving blood clots in the lungs. It aimed to see how well the catheter worked and how doctors liked using it. However, the study was withdrawn before any patients were enrolled, so no results are availab…
Matched conditions: LUNG DISEASES
Sponsor: Liquet Medical Inc. • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
Last-Resort drug access opens for rare lung cancer patients
Disease control NO_LONGER_AVAILABLEThis program offers taletrectinib to adults with advanced or spreading ROS1-positive non-small cell lung cancer who cannot use approved treatments or join ongoing studies. Participants must have a ROS1 gene fusion and adequate organ function. The goal is to provide potential bene…
Matched conditions: LUNG DISEASES
Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated May 17, 2026 02:05 UTC
-
New combo therapy shows promise for common lung cancer mutation
Disease control OngoingThis study looks at how well the drug osimertinib combined with chemotherapy works as the first treatment for people with advanced EGFR-mutated non-small cell lung cancer. About 532 adults with stage IIIB, IIIC, or IV lung cancer that cannot be surgically removed are being observ…
Matched conditions: LUNG DISEASES
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
New Clot-Busting device could save lungs in emergency
Disease control OngoingThis study tests a new device called the Aventus Thrombectomy System to safely remove blood clots from the lungs in people with a sudden, severe pulmonary embolism. About 130 adults aged 18 to 80 with symptoms lasting less than two weeks will be enrolled. The goal is to see if th…
Matched conditions: LUNG DISEASES
Phase: NA • Sponsor: Inquis Medical, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New hope for PAH patients: Long-Term drug safety trial underway
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of the drug ralinepag in people with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe. About 1,000 adults who have already been in earlier ralinepag studies will take the drug and be monitored f…
Matched conditions: LUNG DISEASES
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New inhaled therapy shows promise for Hard-to-Treat lung condition
Disease control OngoingThis study tests an inhaled medicine called mosliciguat in 135 people who have high blood pressure in their lungs due to scarring lung disease. The goal is to see if it improves blood flow and walking ability over 16 weeks. Participants are randomly assigned to receive the drug o…
Matched conditions: LUNG DISEASES
Phase: PHASE2 • Sponsor: Pulmovant, Inc. • Aim: Disease control
Last updated May 04, 2026 16:19 UTC
-
Fish oil and turmeric root may shrink Pre-Cancer lung spots
Disease control OngoingThis study tests whether a combination of fish oil (Lovaza) and curcumin (from turmeric root) can reduce the size of lung nodules in current and former smokers aged 55 and older. Nineteen participants took the supplements for 6 months to see if nodules shrank and if the treatment…
Matched conditions: LUNG DISEASES
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Apr 24, 2026 16:18 UTC
-
Can doctor training boost lung cancer treatment in smaller hospitals?
Knowledge-focused OngoingThis study looks at whether educating doctors in smaller city and county hospitals can improve how they test and treat patients with advanced non-small cell lung cancer. About 1000 patients will be observed to see if more patients get the right molecular tests and targeted therap…
Matched conditions: LUNG DISEASES
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 17, 2026 02:02 UTC
-
Brain scans reveal hidden links between body diseases and future health
Knowledge-focused OngoingThis study watches how diseases of the lungs, stomach, and hormones change brain metabolism using special PET scans. Researchers follow 200 adults over time to see if these brain changes can predict tumor return, spread, or survival. No treatment is given — the goal is to learn a…
Matched conditions: LUNG DISEASES
Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Firefighters get new screening for hidden lung risks
Knowledge-focused TerminatedThis study aimed to give firefighters low-dose chest CT scans to check for lung cancer and other lung diseases caused by smoke and chemical exposure. It focused on firefighters aged 35 and older who never smoked or quit long ago. The study was withdrawn before enrolling anyone, s…
Matched conditions: LUNG DISEASES
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
AI listens to your lungs to spot disease early
Knowledge-focused OngoingThis study gathers lung sounds from 750 adults—both healthy and those with breathing problems—using a digital stethoscope. The goal is to build an artificial intelligence program that can automatically detect wheezes, crackles, and other abnormal sounds. No treatment is given; th…
Matched conditions: LUNG DISEASES
Sponsor: Eko Devices, Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
600 CF patients join study to uncover why some lungs fare better
Knowledge-focused OngoingThis study looks at how different genes can make cystic fibrosis lung disease better or worse in different people. Researchers are studying 600 people with CF to find genetic clues that explain why some have milder lung problems. The goal is to learn more, not to test a new treat…
Matched conditions: LUNG DISEASES
Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC